By contrast, the substantial downregulation of TMPRSS2 and ADAM17 in experimental CHF argues against the involvement of these enzymes in the exaggerated susceptibility of CHF patients to attract SARS‐CoV‐2. The gene discussed is ADAM17; the disease is congestive heart failure.